Want to take quizzes and track your credits?
Which features of a postfungal keratitis corneal scar contribute most to vision loss?
In this ancillary cross-sectional study of a subset of 71 patients treated for fungal keratitis in the Mycotic Ulcer Treatment Trial I, irregular astigmatism and scar density were the features most strongly associated with vision loss. The thinnest point of the cornea was the metric that best discriminated between the natamycin- and voriconazole-treated ulcers.
The findings of this study suggest that irregular astigmatism, scar density, and the thinnest point of the cornea may be meaningful cornea-specific metrics that could be used as outcomes in clinical research.
Corneal opacity is a leading cause of visual impairment worldwide; however, the specific features of corneal scars, which decrease visual acuity, have not been well characterized.
To investigate which features of a postfungal keratitis corneal scar contribute to decreased visual acuity after an episode of infectious keratitis and evaluate whether any corneal features may be used as outcomes for clinical trials.
Design, Setting, and Participants
In this ancillary, prospective cross-sectional study, a subset of study participants treated for fungal keratitis (n = 71) as part of the Mycotic Ulcer Treatment Trial I (MUTT I) underwent best spectacle-corrected visual acuity (BSCVA) and best contact lens–corrected visual acuity examination, Scheimpflug imaging, and anterior segment optical coherence tomography at a referral hospital in India approximately 2 years after enrollment. Data were collected from December 3, 2012, to December 19, 2012, and analyses were performed from December 2, 2013, to October 2, 2019.
Main Outcomes and Measures
Linear regression models were used to evaluate the importance of various corneal features for BSCVA and to assess whether these features could be used to differentiate the 2 treatment arms of the MUTT I trial.
Seventy-one patients (42 men [59.1%]; median age, 48 [range, 39-60] years) were examined at a median (IQR) time of 1.8 (1.4-2.2) years after enrollment. The mean (SD) logMAR BSCVA was 0.17 (0.19) (Snellen equivalent, 20/32). In multivariable linear regression models, BSCVA was most associated with irregular astigmatism (1.0 line of worse BSCVA per 1-line difference between BSCVA and contact lens visual acuity; 95% CI, 0.6-1.4) and corneal scar density (1.5 lines of worse vision per 10-unit increase in the mean central corneal density; 95% CI, 0.8-2.3). The thinnest point of the cornea was the metric that best discriminated between the natamycin- and voriconazole-treated ulcers in MUTT I, with 29.3 μm (95% CI, 7.1-51.6 μm) less thinning in natamycin-treated eyes.
Conclusions and Relevance
Both irregular astigmatism and corneal scar density may be important risk factors for BSCVA in a population with relatively mild, healed fungal corneal ulcers. The thinnest point of the corneal scar may be a cornea-specific outcome that could be used to evaluate treatments for corneal ulcers.
Sign in to take quiz and track your certificates
JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 CME Credit™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC
Accepted for Publication: October 07, 2019.
Corresponding Author: Jeremy D. Keenan, MD, MPH, Francis I Proctor Foundation, Department of Ophthalmology, University of California, San Francisco, 513 Parnassus Ave, MedSci S334, San Francisco, CA 94143 (email@example.com).
Published Online: December 5, 2019. doi:10.1001/jamaophthalmol.2019.4852
Author Contributions: Dr Keenan had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Menda, Das, Acharya, Lietman, McLeod, Keenan.
Acquisition, analysis, or interpretation of data: Menda, Panigrahi, Prajna, Acharya, Keenan.
Drafting of the manuscript: Keenan.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: Keenan.
Administrative, technical, or material support: Menda, Panigrahi, Prajna, Acharya, Lietman, McLeod.
Supervision: Prajna, Acharya, McLeod, Keenan.
Conflict of Interest Disclosures: None reported.
Funding/Support: The study was supported by grants U10EY018573 (Dr Lietman), K23EY017897 (Dr Acharya), and K23EY019071 (Dr Keenan) from the National Eye Institute and grants from That Man May See, the Harper/Inglis Trust, the South Asia Research Foundation, and Research to Prevent Blindness (Drs Acharya, Lietman, and Keenan).
Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
You currently have no searches saved.